Tran Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fair Isaac
FICO
|
+$17.4M |
| 2 |
Elevance Health
ELV
|
+$14.8M |
| 3 |
Capital One
COF
|
+$11.5M |
| 4 |
Netflix
NFLX
|
+$7.76M |
| 5 |
Tenet Healthcare
THC
|
+$5.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Builders FirstSource
BLDR
|
+$16.4M |
| 2 |
TLN
Talen Energy Corp
TLN
|
+$15M |
| 3 |
Jefferies Financial Group
JEF
|
+$14.8M |
| 4 |
e.l.f. Beauty
ELF
|
+$11.4M |
| 5 |
IQVIA
IQV
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.74% |
| 2 | Communication Services | 12.56% |
| 3 | Industrials | 10.23% |
| 4 | Healthcare | 10.06% |
| 5 | Consumer Discretionary | 9.81% |
Similar funds
Tran Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Tran Capital Management held 71 positions worth $850M, up 14% from $743M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Tran Capital Management withdrew a net $29.3M in Q2 2025, closing 3 positions and reducing 28 holdings. Its most notable exit was Jefferies Financial Group, an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, Tran Capital Management opened a new position in Elevance Health worth $14.3M.
- Tran Capital Management's largest Q2 2025 buy was Elevance Health: 36,817 shares worth $14.3M.
- Tran Capital Management added most to Fair Isaac in Q2 2025, an estimated $17.4M increase.
- Tran Capital Management's biggest Q2 2025 reduction was Builders FirstSource, cutting an estimated $16.4M.
- Tran Capital Management fully exited Jefferies Financial Group in Q2 2025, selling an estimated $14.8M.
- Tran Capital Management's ten largest holdings make up 56% of its $850M portfolio in Q2 2025.
- Tran Capital Management opened 6 new positions and closed 3 in Q2 2025.
- Tran Capital Management's portfolio value rose 14% quarter-over-quarter to $850M.
Based on Tran Capital Management's 13F filing for Q2 2025, filed 14 Jul 2025.